首页> 外文期刊>Nature medicine >BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint
【24h】

BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint

机译:Bach2在BE B细胞受体检查点处介导负选择和P53依赖性肿瘤抑制

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The B cell-specific transcription factor BACH2 is required for affinity maturation of B cells. Here we show that Bach2-mediated activation of p53 is required for stringent elimination of pre-B cells that failed to productively rearrange immunoglobulin VH-DJH gene segments. After productive VH-DJH gene rearrangement, pre-B cell receptor signaling ends BACH2-mediated negative selection through B cell lymphoma 6 (BCL6)-mediated repression of p53. In patients with pre-B acute lymphoblastic leukemia, the BACH2-mediated checkpoint control is compromised by deletions, rare somatic mutations and loss of its upstream activator, PAX5. Low levels of BACH2 expression in these patients represent a strong independent predictor of poor clinical outcome. In this study, we demonstrate that Bach2+l+ pre-B cells resist leukemic transformation by Myc through Bach2-dependent upregulation of p53 and do not initiate fatal leukemia in transplant-recipient mice. Chromatin immunoprecipitation sequencing and gene expression analyses carried out by us revealed that BACH2 competes with BCL6 for promoter binding and reverses BCL6-mediated repression of p53 and other cell cycle checkpoint-control genes. These findings identify BACH2 as a crucial mediator of negative selection at the pre-B cell receptor checkpoint and a safeguard against leukemogenesis.
机译:B细胞特异性转录因子Bach2是B细胞的亲和力成熟所必需的。在这里,我们表明,P53的BACH2介导的P53激活是严格的消除未能高效地重新排列免疫球蛋白VH-DJH基因区段的预活性。在生产VH-DJH基因重排之后,BACH2介导通过B细胞淋巴瘤6(BCL6)介导的P53的抑制后的BACH2介导的阴性选择。在B前急性淋巴细胞白血病患者中,BACH2介导的检查点控制受到缺失,稀有体细胞突变和其上游活化剂的损失,PAX5受到损害。这些患者中的低水平的Bach2表达代表了临床结果不良的强烈独立预测因子。在这项研究中,我们证明了BACH2 + L +前B细胞通过P53的依赖性上调抵抗MYC的白血病转化,并且不会在移植受体小鼠中引发致命的白血病。美国进行的染色质免疫沉淀序列和基因表达分析显示,BACH2与BCL6竞争启动子结合,反转BCL6介导的P53和其他细胞周期检查点对照基因的抑制。这些发现将Bach2鉴定为在B前B细胞受体检查点处的阴性选择的关键介质和对白血病的保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号